666
Participants
Start Date
September 1, 2021
Primary Completion Date
June 15, 2022
Study Completion Date
June 15, 2022
Aspirin
Participant's mothers were administered 81mg of Aspirin throughout their pregnancy with the participant.
Placebo
Participant's mothers were administered placebo throughout their pregnancy with the participant.
Columbia University, New York
Thomas Jefferson University, Philadelphia
Christiana Care, Newark
University of North Carolina School of Medicine, Chapel Hill
RTI International, Research Triangle Park
University of Alabama, Birmingham, Birmingham
University of Colorado Health Sciences Center, Denver
Boston University, Boston
Kinshasa School of Public Health, Kinshasa
INCAP, Guatemala City
Jawaharlal Nehru Medical College, Belagavi
Lata Medical Research Foundation, Nagpur
Aga Khan University, Karachi
University Teaching Hospital, Lusaka
Thomas Jefferson University
OTHER
RTI International
OTHER
Thrasher Research Fund
OTHER
NICHD Global Network for Women's and Children's Health
NETWORK